 |
answer text |
<p>Genomic testing is already in use as part of the diagnostic pathway for blood cancer.
Through implementation of the NHS Genomic Medicine Service, NHS England and NHS Improvement
are ensuring consistent and equitable access to genomic testing.</p><p> </p><p>The
NHS Long Term Plan sets out the ambition to embed genomic medicine, including whole
genome sequencing, into routine clinical care. It is expected that within the next
year whole genome sequencing (WGS) will begin to be available for:</p><p>- Seriously
ill children likely to have a rare genetic disorder;</p><p>- People with one of 21
rare conditions where current evidence supports early adoption of WGS as a diagnostic
test; and</p><p>- People with specific types of cancer for which there is likely to
be the greatest patient benefit from using WGS – children with cancer, sarcoma and
acute myeloid leukaemia.</p><p> </p><p> </p>
|
 |
